Recognizing Lean Liver Disease in Clinical Practice Clinicians should consider metabolic liver disease in patients who present with: Normal BMI but central adiposity (increased waist circumference) Mildly elevated liver enzymes without a clear cause Dyslipidemia or insulin resistance features Fatty liver on incidental imaging Routine use of noninvasive tests such as FIB4, ELF score, or transient elastography can help stratify risk and guide hepatology referrals
Therefore, the information pharmacist team of our hospital pays close attention to the new drug dynamics of GLP-1RA drugs, the information of post-marketing re-evaluation of drugs, pharmacological properties, clinical application, occurrence of adverse reactions, etc
Engineering stimuli-activatable boolean logic prodrug nanoparticles for combination cancer immunotherapy
Lost 3 st in a year Discreet, simple and genuinely supportive
1 This efficiency is driven by Monthly Online Revenue per Average Subscriber which jumped 53% to $84 in early 2025 as patients adopted multi-product treatment plans